|Articles|December 29, 2021

Successful Weight-Loss Surgery Reduces Risk of Severe COVID-19

Author(s)Nina Cosdon

COVID-19 patients who underwent prior weight-loss surgery were significantly less likely to experience severe disease outcomes.

Previous research has shown obesity is closely correlated with severe COVID-19 illness.

Patients who lost weight due to bariatric surgery prior to COVID-19 infection were less likely to experience drastic outcomes than patients with obesity, a Cleveland Clinic study found.

The observational study, published today in JAMA Surgery, examined whether formerly obese patients who underwent successful weight-loss intervention subsequently had less severe COVID-19 illness. It included 20212 adults with obesity, classified by a body mass index (BMI) of at least 35.

Patients (n=5053) who underwent weight-loss surgery from 2004-2017 were matched 1:3 to patients with obesity who did not have the surgery (n=15159). Prior to Cleveland’s COVID-19 outbreak on March 1, 2020, patients who had bariatric surgery saw a comparative 19% reduce in weight.

Investigators examined rate of contracting COVID-19, hospitalization, need for supplemental oxygen, and severe disease. “Severe disease” was defined as intensive care unit (ICU) admission, mechanical ventilation need, or death.

Both groups had similar rates of COVID-19 infection; 9.1% in the group that had surgery and 8.7% in the group that did not. However, participants who underwent weight-loss surgery had significantly better outcomes.

Patients with prior bariatric surgery who contracted COVID-19 were had a 49% lower risk of hospitalization, 63% reduced need for supplemental oxygen, and 60% risk reduction in developing severe COVID-19.

The study’s lead author, Ali Aminian, MD, said, “Patients with obesity who achieved substantial and sustained weight loss with bariatric surgery prior to a COVID-19 infection reduced their risk of developing severe illness by 60 percent.” Aminian noted that the patients who underwent weight-loss surgery were healthier at the time they contracted COVID-19, leading to better outcomes.

Aminian, also the director of Cleveland Clinic’s Bariatric and Metabolic Institute, added, “Our study provides strong evidence that obesity is a modifiable risk factor for COVID-19 that can be improved through a successful weight-loss intervention.”


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.